Kimia is a drug discovery company applying high throughput precision chemistry in combination.
Kimia Therapeutics has raised $55.0M in total funding. The most recent round was Series A. The last funding was announced in December 2023.
Kimia Therapeutics's investors include Dimension Capital, The Column Group, Horizons Ventures, Zachary Hargreaves.
Kimia Therapeutics is headquartered in Berkeley, United States.
Kimia is a drug discovery company applying high throughput precision chemistry in combination.
Kimia Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kimia Therapeutics — Funding & Investors." VCBacked, December 19, 2023, https://www.vcbacked.co/company/kimia-therapeutics. Accessed July 28, 2026.
VCBacked. (2023). Kimia Therapeutics — Funding & Investors. Retrieved July 28, 2026, from https://www.vcbacked.co/company/kimia-therapeutics
{{cite web |title=Kimia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kimia-therapeutics |website=VCBacked |access-date=July 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated